IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BOSSI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.868
AS - Asia 9.485
EU - Europa 5.125
SA - Sud America 2.119
AF - Africa 228
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 4
Totale 32.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.581
SG - Singapore 3.183
CN - Cina 2.438
HK - Hong Kong 1.885
BR - Brasile 1.800
UA - Ucraina 887
VN - Vietnam 707
IT - Italia 652
DE - Germania 618
FR - Francia 391
IE - Irlanda 390
PL - Polonia 389
TR - Turchia 389
RU - Federazione Russa 383
GB - Regno Unito 357
FI - Finlandia 328
EE - Estonia 295
IN - India 205
AR - Argentina 138
CA - Canada 126
ID - Indonesia 123
BD - Bangladesh 113
SE - Svezia 107
MX - Messico 90
IQ - Iraq 84
AT - Austria 83
ZA - Sudafrica 81
NL - Olanda 55
EC - Ecuador 54
PK - Pakistan 52
JP - Giappone 50
SA - Arabia Saudita 45
CZ - Repubblica Ceca 44
ES - Italia 42
EG - Egitto 39
CO - Colombia 31
MA - Marocco 29
VE - Venezuela 28
PY - Paraguay 26
UZ - Uzbekistan 26
NP - Nepal 22
JO - Giordania 21
AU - Australia 20
CH - Svizzera 17
KE - Kenya 17
MY - Malesia 17
PE - Perù 17
AZ - Azerbaigian 15
BE - Belgio 13
IL - Israele 13
JM - Giamaica 13
CL - Cile 12
TN - Tunisia 12
CR - Costa Rica 11
KZ - Kazakistan 11
AE - Emirati Arabi Uniti 10
DO - Repubblica Dominicana 10
IR - Iran 10
LT - Lituania 10
DZ - Algeria 9
ET - Etiopia 8
HN - Honduras 8
OM - Oman 8
PH - Filippine 8
AL - Albania 7
PA - Panama 7
SN - Senegal 7
UY - Uruguay 7
BH - Bahrain 6
HR - Croazia 6
LB - Libano 6
LY - Libia 6
MK - Macedonia 6
NI - Nicaragua 6
TH - Thailandia 6
AO - Angola 5
DK - Danimarca 5
KG - Kirghizistan 5
MD - Moldavia 5
PT - Portogallo 5
BB - Barbados 4
EU - Europa 4
GR - Grecia 4
KR - Corea 4
LK - Sri Lanka 4
MU - Mauritius 4
TT - Trinidad e Tobago 4
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
GE - Georgia 3
GT - Guatemala 3
KW - Kuwait 3
MT - Malta 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
CI - Costa d'Avorio 2
GH - Ghana 2
GY - Guiana 2
Totale 32.814
Salva come PNG Salva come JPEG
Città #
Fairfield 2.231
Hong Kong 1.876
Ashburn 1.603
Singapore 1.543
Seattle 919
Woodbridge 898
Jacksonville 848
Houston 789
The Dalles 754
Cambridge 694
Wilmington 674
Princeton 636
Beijing 553
San Jose 499
Dallas 457
New York 427
Chandler 416
Warsaw 381
Dublin 347
Istanbul 323
Lauterbourg 303
Tallinn 295
Ann Arbor 282
Helsinki 257
Los Angeles 252
Council Bluffs 241
Ho Chi Minh City 205
Des Moines 170
Nanjing 163
San Diego 152
Redondo Beach 151
São Paulo 138
Hanoi 133
Brescia 122
Buffalo 121
Moscow 104
Munich 98
London 96
Jakarta 85
Milan 83
Chicago 82
Shanghai 81
Changsha 79
Nuremberg 76
Shenyang 75
San Francisco 70
Santa Clara 64
Tianjin 61
Dong Ket 58
Jinan 58
Nanchang 57
Hebei 52
Jiaxing 52
Orem 52
Brooklyn 51
Frankfurt am Main 50
Rome 48
Johannesburg 47
Menlo Park 43
Tokyo 43
Pune 41
Guangzhou 40
Rio de Janeiro 40
Belo Horizonte 38
Turku 37
Montreal 36
Toronto 36
Hangzhou 35
Chennai 34
Vienna 34
Brno 33
Haiphong 33
Brasília 32
Curitiba 31
Salt Lake City 30
Baghdad 29
Fortaleza 28
Zhengzhou 28
Campinas 27
Da Nang 27
Denver 27
Lappeenranta 27
Ningbo 27
Kilburn 26
Manchester 25
Boardman 24
Cairo 24
Salvador 24
Atlanta 23
Boston 23
Poplar 23
Norwalk 22
Phoenix 22
Taizhou 21
Amman 20
Schiffdorf 20
Stockholm 20
Tashkent 20
Erbil 19
Guayaquil 19
Totale 22.643
Salva come PNG Salva come JPEG
Nome #
A randomized, phase 2 study of cetuximab plus cisplatin with or without paclitaxel for the first-line treatment of patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck 812
Systematic review of photobiomodulation for the managementof oral mucositis in cancer patients and clinical practice guidelines 359
Systematic review of natural and miscellaneous agents for the management of oral mucositis in cancer patients and clinical practice guidelines-part 1: vitamins, minerals, and nutritional supplements. 321
The 8th TNM classification for oral squamous cell carcinoma: What is gained, what is lost, and what is missing 232
Prognostic Nomograms in Oral Squamous Cell Carcinoma: The Negative Impact of Low Neutrophil to Lymphocyte Ratio 222
Clinical and histological prognostic factors of recurrent and/or metastatic salivary gland adenoid cystic carcinoma 221
Pretreatment DWI with Histogram Analysis of the ADC in Predicting the Outcome of Advanced Oropharyngeal Cancer with Known Human Papillomavirus Status Treated with Chemoradiation 206
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 205
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 190
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 175
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions 172
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 169
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 166
Tumor biomarkers for the prediction of distant metastasis in head and neck squamous cell carcinoma 165
Malignant tumors of the maxillary sinus: Prognostic impact of neurovascular invasion in a series of 138 patients 165
Acute skin toxicity management in head and neck cancer patients treated with radiotherapy and chemotherapy or EGFR inhibitors: Literature review and consensus 164
Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma 160
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas: Translational analyses and clinical impact 159
Systemic therapy in metastatic salivary gland carcinomas: A pathology-driven paradigm? 157
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 152
Activity and safety of afatinib in a window preoperative EORTC study in patients with squamous cell carcinoma of the head and neck (SCCHN) 152
Systematic review of natural and miscellaneous agents, for the management of oral mucositis in cancer patients and clinical practice guidelines - part 2: honey, herbal compounds, saliva stimulants, probiotics, and miscellaneous agents 151
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 150
Baseline prognostic factors affecting survival in recurrent and/or metastatic salivary gland adenoid cystic carcinoma 150
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 148
Activity of abiraterone in rechallenging two AR-expressing salivary gland adenocarcinomas, resistant to androgen-deprivation therapy 143
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 136
Sepsis in head and neck cancer patients treated with chemotherapy and radiation: Literature review and consensus 135
A European survey on the practice of nutritional interventions in head–neck cancer patients undergoing curative treatment with radio(chemo)therapy 135
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor 133
Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis 132
A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin 131
Not all hematopoietic growth factors are created equal: Should we gain information for their use with immunotherapy? 131
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 130
Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients 130
Precision medicine in rare tumors and the need for multicenter trials and international collaboratives: Sinonasal cancer as paradigm 130
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 130
Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders 128
Folate in head and neck squamous cell cancer chemoprevention: Purposely left out? 128
Assessing Preferences in Patients with Head and Neck Squamous Cell Carcinoma: Phase I and II of Questionnaire Development 127
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 127
A ct-based radiomic signature can be prognostic for 10-months overall survival in metastatic tumors treated with nivolumab: An exploratory study 126
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 125
Investigational drugs for head and neck cancer 125
Clinical activity of androgen deprivation therapy in patients with metastatic/relapsed androgen receptor-positive salivary gland cancers 124
Cumulative cisplatin dose in concurrent chemoradiotherapy for head and neck cancer: A systematic review 124
T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results 124
The role of systemic therapy in the management of sinonasal cancer: A critical review 124
Safety and feasibility of every-other-week maintenance cetuximab after first-line chemotherapy in patients with recurrent or metastatic head and neck squamous cell cancer 123
A NATURAL HISTORY OF A SERIES OF RADIOACTIVE IODINE (131I-RAI)-RESISTANT ADVANCED DIFFERENTIATED THYROID CANCER (DTC) 119
Mining of self-organizing map gene-expression portraits reveals prognostic stratification of HPV-positive head and neck squamous cell carcinoma 119
Hope in cancer patients: the relational domain as a crucial factor 118
Multikinase inhibitors in thyroid cancer 118
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 118
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 117
Regional disease in head and neck cutaneous squamous cell carcinoma: the role of primary tumor characteristics and number of nodal metastases 117
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 116
Health care-associated infections in patients with head and neck cancer treated with chemotherapy and/or radiotherapy 116
Receptor tyrosine kinase profiles and human papillomavirus status in oropharyngeal squamous cell carcinoma 116
Advanced lung cancer inflammation index and its prognostic value in HPV-negative head and neck squamous cell carcinoma: a multicentre study 116
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study 115
Uso di miRNA come biomarcatori per la diagnosi e prognosi del carcinoma orale a cellule squamose 114
Italian version of the MD Anderson Symptom Inventory-Head and Neck Module: linguistic validation 114
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 114
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 114
Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma 114
Feasibility and activity of docetaxel, cisplatinum and 5-fluorouracil induction chemotherapy followed by concurrent chemo-radiotherapy (including IMRT) in locally advanced undifferentiated nasopharyngeal cancer (LANPC) 114
TP53 Mutations and Pathologic Complete Response to Neoadjuvant Cisplatin and Fluorouracil Chemotherapy in Resected Oral Cavity Squamous Cell Carcinoma 113
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis 113
Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma 112
Functional Genomics Uncover the Biology behind the Responsiveness of Head and Neck Squamous Cell Cancer Patients to Cetuximab 112
A functional gene expression analysis in epithelial sinonasal cancer: Biology and clinical relevance behind three histological subtypes 112
New Challenges in Evaluating Outcomes after Immunotherapy in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma 111
New insights in chemotherapy 111
Nausea and vomiting during the first 3 intercycle periods in chemo-naive cancer patients receiving moderately/highly emetogenic therapy 111
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 110
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 110
Preoperative chemotherapy in advanced resectable OCSCC: long-term results of a randomized phase III trial 110
Treatment Stratification in First-Line Recurrent or Metastatic Head and Neck Cancer, on Behalf of the EORTC Young Investigator Head and Neck Cancer Group 110
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients 109
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 109
The Benefit of a Multidisciplinary Approach to the Patient Treated with (Chemo) Radiation for Head and Neck Cancer 109
NICSO: Network Italiano Cure di Supporto in Oncologia - Italian Network for Supportive Care in Oncology 109
Emerging tyrosine kinase inhibitors for head and neck cancer 109
The Case Volume Issue in Head and Neck Oncology 109
A complete remission with androgen-deprivation therapy in a recurrent androgen recptor-expressing adenocarcinoma of the parotid gland [1] 109
Clinical outcomes, Kadish-INSICA staging and therapeutic targeting of somatostatin receptor 2 in olfactory neuroblastoma 109
Differential impact of cisplatin dose intensity on human papillomavirus (HPV)-related (+) and HPV-unrelated (-) locoregionally advanced head and neck squamous cell carcinoma (LAHNSCC) 108
Circulating pretreatment Epstein Barr Virus DNA quantification as a prognostic factor in nasopharyngeal cancer patients in a non endemic area 108
Gastrointestinal toxicities from targeted therapies: measurement, duration and impact 108
Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements 108
Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up 108
Radiotherapy for unresectable sinonasal cancers: Dosimetric comparison of intensity modulated radiation therapy with coplanar and non-coplanar volumetric modulated arc therapy 107
Head and neck cancer subtypes with biological and clinical relevance: Meta-analysis of gene-expression data 107
Primary resistances to EGFR inhibitors (EGFRi) in HPV-positive and -negative oropharyngeal squamous cell carcinoma (OSCC) 107
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 106
Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy 106
Pain related to cancer treatments and diagnostic procedures: a no man's land? 106
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 105
Role of induction chemotherapy in the multimodal management of locally advanced epithelial sinonasal cancer 105
Totale 14.109
Salva come PNG Salva come JPEG
Categoria #
all - tutte 193.513
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 193.513
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.371 0 0 0 0 0 0 0 0 0 723 284 364
2021/20222.337 116 253 56 283 109 212 76 202 120 195 201 514
2022/20231.518 359 89 46 113 92 464 8 96 144 26 37 44
2023/20242.385 64 36 117 107 122 577 90 137 665 39 33 398
2024/20255.799 32 21 69 1.028 543 536 336 134 730 555 1.132 683
2025/202611.344 1.063 2.379 1.309 1.712 773 632 1.471 462 715 828 0 0
Totale 33.266